- Home
- ABBV vs SAN Comparison
ABBV vs SAN Comparison
Compare ABBV & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABBV | SAN |
|---|---|---|
| Founded | 2012 | 1857 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.9B | 191.8B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABBV | SAN |
|---|---|---|
| Price | $220.64 | $10.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 1 |
| Target Price | ★ $247.06 | N/A |
| AVG Volume (30 Days) | 5.4M | ★ 16.2M |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.07% | 1.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.36 | N/A |
| Revenue | ★ $61,160,000,000.00 | N/A |
| Revenue This Year | $11.90 | $33.83 |
| Revenue Next Year | $8.24 | $5.67 |
| P/E Ratio | $95.47 | ★ $11.21 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $164.39 | $5.54 |
| 52 Week High | $244.81 | $13.24 |
Technical Indicators
Market Signals| Indicator | ABBV | SAN |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 36.96 |
| Support Level | $207.88 | $9.84 |
| Resistance Level | $231.00 | $11.13 |
| Average True Range (ATR) | 5.15 | 0.36 |
| MACD | -1.18 | -0.13 |
| Stochastic Oscillator | 1.87 | 1.20 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.